ArticleJACS Au2025
Efficient Synthesis of Protein-Polymer Conjugates with Open-Air Fabrication and Facile Purification Driven by the Thermoresponsive Protein-Polymer Conjugate.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oxygen-Tolerant Photo-Induced Miniaturized Accelerated Atom Transfer Radical Polymerization (OPTIMA-ATRP) for High-Throughput Synthesis of Polymer Bioconjugates.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A simple, efficient, and broadly applicable method for the preparation of protein-polymer conjugates is of critical importance for their further development. However, existing approaches are often limited by challenges such as insufficient deoxygenation, complex purification processes, and poor compatibility of monomers and proteins. Herein, we present a comprehensive strategy for the synthesis of protein-polymer conjugates utilizing a thermosensitive, recyclable glucose oxidase-poly-(di-(ethylene glycol) methyl ether methacrylate) conjugate (GOX-PDEGMA) as part of the deoxygenation system. This strategy enables controlled polymerization under open-air conditions across volumes ranging from 10 μL to 100 mL, with the deoxygenation reagent being conveniently removed via phase transition postreaction. Notably, this strategy demonstrates excellent polymerization control, high retention of end-group, a straightforward and modular purification process, and compatibility with five different types of methacrylate monomers. It is also adaptable to a wide range of proteins, including antibodies, cytokines, and enzymes, while preserving their bioactivity. The development of this strategy not only expands the potential applications of protein-polymer conjugates in the synthesis of other conjugates but also unlocks new opportunities for their advanced use in biopharmaceuticals and related fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.